Article
Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
2022-04-02
Abstract excerpt
<h4>ABSTRACT</h4> Chemotherapy resistance and relapses are common in high-risk neuroblastoma (NB), an aggressive pediatric solid tumor of the sympathetic nervous system. Here, we developed a clinically-relevant in vivo treatment protocol mimicking the first line five-chemotherapy treatment regimen of high-risk NB and applied this protocol to mice with MYCN -amplified NB patient-derived xenografts (PDXs). Genomic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e7fadc96-0b74-5a18-ae0c-93ccf6c77842
- DOI
- 10.1101/2022.04.01.486670
